SalfaCorp Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de SalfaCorp.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Construction	17.0%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

SalfaCorp (SNSE:SALFACORP) Takes On Some Risk With Its Use Of Debt

Nov 08

At CL$297, Is It Time To Put SalfaCorp S.A. (SNSE:SALFACORP) On Your Watch List?

Jan 27

SalfaCorp (SNSE:SALFACORP) Shareholders Will Want The ROCE Trajectory To Continue

Nov 03

SalfaCorp (SNSE:SALFACORP) Might Be Having Difficulty Using Its Capital Effectively

Nov 23

At CL$310, Is It Time To Put SalfaCorp S.A. (SNSE:SALFACORP) On Your Watch List?

Nov 05

SalfaCorp (SNSE:SALFACORP) Takes On Some Risk With Its Use Of Debt

Oct 18

We Think You Can Look Beyond SalfaCorp's (SNSE:SALFACORP) Lackluster Earnings

Jun 04

SalfaCorp (SNSE:SALFACORP) Seems To Be Using A Lot Of Debt

Mar 24

A Look At The Intrinsic Value Of SalfaCorp S.A. (SNSE:SALFACORP)

Feb 24

Has SalfaCorp (SNSE:SALFACORP) Got What It Takes To Become A Multi-Bagger?

Feb 04

Is SalfaCorp S.A. (SNSE:SALFACORP) An Attractive Dividend Stock?

Jan 16

Reflecting on SalfaCorp's (SNSE:SALFACORP) Share Price Returns Over The Last Three Years

Jan 01

Is SalfaCorp S.A. (SNSE:SALFACORP) Popular Amongst Institutions?

Dec 12

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como SalfaCorp no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

SNSE:SALFACORP - Estimaciones futuras de los analistas y datos financieros pasados (CLP Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2024	1,089,211	43,320	47,227	56,178	N/A
6/30/2024	1,121,378	45,600	55,122	62,869	N/A
3/31/2024	1,092,793	44,441	66,543	74,958	N/A
12/31/2023	1,040,369	42,870	67,903	76,817	N/A
9/30/2023	968,167	43,072	99,599	109,123	N/A
6/30/2023	911,201	42,484	102,983	113,265	N/A
3/31/2023	849,020	40,314	68,908	79,611	N/A
12/31/2022	829,374	35,635	60,018	72,169	N/A
9/30/2022	813,731	33,160	76,268	91,699	N/A
6/30/2022	792,074	29,473	76,036	92,462	N/A
3/31/2022	765,670	27,245	99,929	115,981	N/A
12/31/2021	712,764	30,813	92,816	109,558	N/A
9/30/2021	621,004	30,353	44,173	56,929	N/A
6/30/2021	515,421	25,669	17,151	28,572	N/A
3/31/2021	432,117	20,939	51,319	63,331	N/A
12/31/2020	400,211	13,747	43,859	52,736	N/A
9/30/2020	467,560	16,519	60,577	70,751	N/A
6/30/2020	548,551	18,296	50,617	60,690	N/A
3/31/2020	659,246	21,803	50,050	60,547	N/A
12/31/2019	749,600	23,242	54,360	66,900	N/A
9/30/2019	810,038	27,800	36,951	50,288	N/A
6/30/2019	813,136	27,141	61,939	75,579	N/A
3/31/2019	784,158	26,266	23,265	35,853	N/A
12/31/2018	718,383	25,365	6,187	17,851	N/A
9/30/2018	647,088	22,722	12,213	23,988	N/A
6/30/2018	641,652	23,152	N/A	8,626	N/A
3/31/2018	638,811	23,110	N/A	33,728	N/A
12/31/2017	667,920	24,724	N/A	62,451	N/A
9/30/2017	700,313	27,993	N/A	45,361	N/A
6/30/2017	686,861	27,892	N/A	51,039	N/A
3/31/2017	700,828	25,938	N/A	-6,491	N/A
12/31/2016	696,857	25,164	N/A	-17,339	N/A
9/30/2016	705,415	23,201	N/A	-21,881	N/A
6/30/2016	693,497	23,957	N/A	-1,101	N/A
3/31/2016	645,607	23,391	N/A	17,717	N/A
12/31/2015	625,431	22,814	N/A	78,997	N/A
9/30/2015	630,163	22,780	N/A	129,543	N/A
6/30/2015	686,735	23,815	N/A	101,848	N/A
3/31/2015	763,778	21,441	N/A	126,404	N/A
12/31/2014	863,179	22,300	N/A	63,434	N/A
9/30/2014	968,056	23,850	N/A	11,383	N/A
6/30/2014	1,024,420	21,295	N/A	15,980	N/A
3/31/2014	1,094,471	25,836	N/A	7,351	N/A
12/31/2013	1,059,715	25,033	N/A	4,289	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de SALFACORP es superior a la tasa de ahorro (5.5%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de SALFACORP crezcan más rápidamente que el mercado CL

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de SALFACORP crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de SALFACORP crezcan más rápidamente que el mercado de CL.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de SALFACORP crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de SALFACORP se prevé que sea elevada dentro de 3 años.

SalfaCorp Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 18% to CL$490

Price target increased by 15% to CL$415

Price target decreased to CL$360

Recent updates

New major risk - Financial position

Third quarter 2024 earnings released: EPS: CL$16.87 (vs CL$21.01 in 3Q 2023)

Second quarter 2024 earnings released: EPS: CL$23.10 (vs CL$21.00 in 2Q 2023)

New major risk - Financial position

First quarter 2024 earnings released: EPS: CL$21.13 (vs CL$18.27 in 1Q 2023)

Insufficient new directors

Upcoming dividend of CL$23.40 per share

New major risk - Financial position

Full year 2023 earnings released: EPS: CL$77.96 (vs CL$79.21 in FY 2022)

New minor risk - Financial position

Price target increased by 18% to CL$490

Third quarter 2023 earnings released: EPS: CL$21.01 (vs CL$24.38 in 3Q 2022)

Investor sentiment improves as stock rises 17%

SalfaCorp (SNSE:SALFACORP) Takes On Some Risk With Its Use Of Debt

Second quarter 2023 earnings released: EPS: CL$21.00 (vs CL$20.85 in 2Q 2022)

Price target increased by 15% to CL$415

New minor risk - Shareholder dilution

New minor risk - Share price stability

Upcoming dividend of CL$19.45 per share at 5.9% yield

Full year 2022 earnings released: EPS: CL$79.21 (vs CL$68.49 in FY 2021)

At CL$297, Is It Time To Put SalfaCorp S.A. (SNSE:SALFACORP) On Your Watch List?

Price target decreased to CL$360

Investor sentiment deteriorated over the past week

SalfaCorp (SNSE:SALFACORP) Shareholders Will Want The ROCE Trajectory To Continue

At CL$361, Is SalfaCorp S.A. (SNSE:SALFACORP) Worth Looking At Closely?

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CL$20.84 (vs CL$15.89 in 2Q 2021)

SalfaCorp (SNSE:SALFACORP) Has More To Do To Multiply In Value Going Forward

Upcoming dividend of CL$20.55 per share

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Is SalfaCorp (SNSE:SALFACORP) A Risky Investment?

Investor sentiment improved over the past week

SalfaCorp (SNSE:SALFACORP) Might Be Having Difficulty Using Its Capital Effectively

Third quarter 2021 earnings released: EPS CL$16.18 (vs CL$5.77 in 3Q 2020)

Investor sentiment improved over the past week

At CL$310, Is It Time To Put SalfaCorp S.A. (SNSE:SALFACORP) On Your Watch List?

SalfaCorp (SNSE:SALFACORP) Takes On Some Risk With Its Use Of Debt

Second quarter 2021 earnings released: EPS CL$15.89 (vs CL$5.38 in 2Q 2020)

We Think You Can Look Beyond SalfaCorp's (SNSE:SALFACORP) Lackluster Earnings

Investor sentiment deteriorated over the past week

Upcoming dividend of CL$9.17 per share

SalfaCorp (SNSE:SALFACORP) Seems To Be Using A Lot Of Debt

New 90-day high: CL$545

A Look At The Intrinsic Value Of SalfaCorp S.A. (SNSE:SALFACORP)

Full year 2020 earnings released: EPS CL$30.56 (vs CL$51.66 in FY 2019)

Has SalfaCorp (SNSE:SALFACORP) Got What It Takes To Become A Multi-Bagger?

Is SalfaCorp S.A. (SNSE:SALFACORP) An Attractive Dividend Stock?

New 90-day high: CL$432

Reflecting on SalfaCorp's (SNSE:SALFACORP) Share Price Returns Over The Last Three Years

Is SalfaCorp S.A. (SNSE:SALFACORP) Popular Amongst Institutions?

Third quarter 2020 earnings released: EPS CL$5.77

New 90-day low: CL$396

New 90-day low: CL$400

First half earnings released

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento